Literature DB >> 17965276

Role of angiotensin II in endothelial dysfunction induced by lipopolysaccharide in mice.

Donald D Lund1, Robert M Brooks, Frank M Faraci, Donald D Heistad.   

Abstract

Endotoxin [or lipopolysaccharide (LPS)] increases levels of superoxide in blood vessels and impairs vasomotor function. Angiotensin II plays an important role in the generation of superoxide in several disease states, including hypertension and heart failure. The goal of this study was to determine whether the activation of the renin-angiotensin system contributes to oxidative stress and endothelial dysfunction after endotoxin. We examined the effects of enalapril (an angiotensin-converting enzyme inhibitor) or L-158809 (an angiotensin receptor blocker) on increases of superoxide and vasomotor dysfunction in mice treated with LPS. C57BL/6 mice were treated with either enalapril (60 mg.kg(-1).day(-1)) or L-158809 (30 mg.kg(-1).day(-1)) for 4 days. After the third day, LPS (10-20 mg/kg) or vehicle was injected intraperitoneally, and one day later, vasomotor function of the aorta was examined in vitro. After precontraction with PGF(2alpha), the maximal responses to sodium nitroprusside were similar in the aorta from normal and LPS-treated mice. In contrast, the relaxation to acetylcholine was impaired after LPS (54 +/- 5% at 10(-5), mean +/- SE) compared with vessels treated with vehicle (88 +/- 1%; P < 0.05). Enalapril improved (P < 0.05) relaxation in response to acetylcholine to 81 +/- 6% after LPS. L-158809 also improved relaxation in response to acetylcholine to 77 +/- 4% after LPS. Superoxide (measured with lucigenin and hydroethidine) was increased (P < 0.05) in aorta after LPS, and levels were reduced (P < 0.05) following enalapril and L-158809. Thus, after LPS, enalapril and L-158809 reduce superoxide levels and improve relaxation to acetylcholine in the aorta. The findings suggest that activation of the renin-angiotensin system contributes importantly to oxidative stress and endothelial dysfunction after endotoxin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965276     DOI: 10.1152/ajpheart.01116.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  18 in total

Review 1.  Year in review 2010: Critical Care--Multiple organ dysfunction and sepsis.

Authors:  Etienne de Montmollin; Djillali Annane
Journal:  Crit Care       Date:  2011-12-05       Impact factor: 9.097

Review 2.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

Review 3.  Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms.

Authors:  Sasha A Fahme; Gerald S Bloomfield; Robert Peck
Journal:  Hypertension       Date:  2018-05-18       Impact factor: 10.190

Review 4.  Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.

Authors:  David S Fedson
Journal:  Ann Transl Med       Date:  2016-11

5.  Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis.

Authors:  Sandra Dial; Sharon J Nessim; Abbas Kezouh; Jacques Benisty; Samy Suissa
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

6.  Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis.

Authors:  Kevin C Doerschug; Angela S Delsing; Gregory A Schmidt; Alix Ashare
Journal:  Crit Care       Date:  2010-02-22       Impact factor: 9.097

Review 7.  Diabetes, insulin, and development of acute lung injury.

Authors:  Shyoko Honiden; Michelle N Gong
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

8.  Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen.

Authors:  Enrique Sánchez-Lemus; Julius Benicky; Jaroslav Pavel; Ignacio M Larrayoz; Jin Zhou; Martina Baliova; Tsuyoshi Nishioku; Juan M Saavedra
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-18       Impact factor: 3.619

9.  What is the role of renin inhibition during rat septic conditions: preventive effect of aliskiren on sepsis-induced lung injury.

Authors:  Erol Akpinar; Zekai Halici; Elif Cadirci; Yasin Bayir; Emre Karakus; Muhammet Calik; Atilla Topcu; Beyzagul Polat
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-09       Impact factor: 3.000

10.  Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.

Authors:  Liqun Ren; Naifeng Liu; Hong Zhi; Yingjuan Li; Yanzhi Li; Rining Tang; Zulong Sheng
Journal:  Cardiovasc Diabetol       Date:  2011-01-26       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.